{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:20:15Z","timestamp":1648984815083},"reference-count":27,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/or.2012.2081","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T11:13:47Z","timestamp":1350386027000},"page":"244-252","source":"Crossref","is-referenced-by-count":0,"title":["Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA"],"prefix":"10.3892","volume":"29","author":[{"given":"YUCHUN","family":"LIU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YONGMEI","family":"SHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENHAO","family":"QIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YIZHEN","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANG","family":"RONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XILONG","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"key20180107214651_b1-or-29-01-0244","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"key20180107214651_b2-or-29-01-0244","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2174\/092986710790979935","article-title":"Recent advances in anti-survivin treatments for cancer","volume":"17","author":"Kanwar","year":"2010","journal-title":"Curr Med Chem"},{"key":"key20180107214651_b3-or-29-01-0244","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","article-title":"Mcl-1 is a potential therapeutic target in multiple types of cancer","volume":"66","author":"Akgul","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"key20180107214651_b4-or-29-01-0244","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12253-008-9076-2","article-title":"Bcl-2 antisense oligonucleotide inhibits the proliferation of childhood leukemia\/lymphoma cells of the B-cell lineage","volume":"14","author":"Szegedi","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"key20180107214651_b5-or-29-01-0244","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.cco.0000142074.67968.eb","article-title":"Bcl-2 antisense therapy in hematologic malignancies","volume":"16","author":"Chanan-Khan","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"key20180107214651_b6-or-29-01-0244","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1517\/17425240802568505","article-title":"Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy","volume":"5","author":"Chen","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"key20180107214651_b7-or-29-01-0244","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.2741\/2943","article-title":"Vector-based delivery of siRNAs: in vitro and in vivo challenges","volume":"13","author":"Walchli","year":"2008","journal-title":"Front Biosci"},{"key":"key20180107214651_b8-or-29-01-0244","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jcp.21790","article-title":"Concepts in in vivo siRNA delivery for cancer therapy","volume":"220","author":"Gondi","year":"2009","journal-title":"J Cell Physiol"},{"key":"key20180107214651_b9-or-29-01-0244","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.exphem.2010.05.005","article-title":"Of mice and men: human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cells","volume":"38","author":"Roelz","year":"2010","journal-title":"Exp Hematol"},{"key":"key20180107214651_b10-or-29-01-0244","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1745-7270.2008.00424.x","article-title":"Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo","volume":"40","author":"Huang","year":"2008","journal-title":"Acta Biochim Biophys Sin"},{"key":"key20180107214651_b11-or-29-01-0244","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00001622-200009000-00002","article-title":"Epidemiology of lymphomas","volume":"12","author":"Baris","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"key20180107214651_b12-or-29-01-0244","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-60327-070-0_4","article-title":"Tollefsbol To RNA interference using a plasmid construct expressing short-hairpin RNA","volume":"405","author":"Lai","year":"2007","journal-title":"Methods Mol Biol"},{"key":"key20180107214651_b13-or-29-01-0244","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"key20180107214651_b14-or-29-01-0244","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddision","year":"2002","journal-title":"Genes Dev"},{"key":"key20180107214651_b15-or-29-01-0244","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbrc.2009.10.020","article-title":"Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing","volume":"390","author":"Zhao","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107214651_b16-or-29-01-0244","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","article-title":"Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods","volume":"9","author":"Sastry","year":"2002","journal-title":"Gene Ther"},{"key":"key20180107214651_b17-or-29-01-0244","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.41.1.506-508.2003","article-title":"Uses and limitation of the XTT assay in studies of Candidar growth and metabolism","volume":"41","author":"Kuhn","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key20180107214651_b18-or-29-01-0244","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.cgt.7700597","article-title":"Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect","volume":"10","author":"Seol","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"key20180107214651_b19-or-29-01-0244","first-page":"1241","article-title":"Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene","volume":"22","author":"Huang","year":"2003","journal-title":"Int J Oncol"},{"key":"key20180107214651_b20-or-29-01-0244","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"BCL-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1998","journal-title":"Nature"},{"key":"key20180107214651_b21-or-29-01-0244","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4419-6706-0_5","article-title":"Targeting survival pathways in lymphoma","volume":"687","author":"Paoluzzi","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"key20180107214651_b22-or-29-01-0244","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol Cell"},{"key":"key20180107214651_b23-or-29-01-0244","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15216540152846046","article-title":"BCL-2 proteins: regulators of the mitochondrial apoptotic program","volume":"52","author":"Gross","year":"2001","journal-title":"IUBMB Life"},{"key":"key20180107214651_b24-or-29-01-0244","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gde.2010.12.001","article-title":"Apoptosis and oncogenesis: give and take in the BCL-2 family","volume":"21","author":"Llambi","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107214651_b25-or-29-01-0244","first-page":"26","article-title":"The effects of RNA interference to Bcl-2 gene on proliferation of human bladder cancer cell line T24","volume":"28","author":"Xu","year":"2007","journal-title":"Chin J Urol"},{"key":"key20180107214651_b26-or-29-01-0244","first-page":"1445","article-title":"Inhibition of Bcl-2 gene expression by siRNA in HL-60 cells","volume":"21","author":"Lei","year":"2005","journal-title":"Chinese Pharmacol Bull"},{"key":"key20180107214651_b27-or-29-01-0244","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.2004.05239.x","article-title":"Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab","volume":"127","author":"Ramanarayanan","year":"2004","journal-title":"Br J Haematol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2081\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:47:04Z","timestamp":1515361624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,16]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/or.2012.2081"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2081","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}